Filing Details
- Accession Number:
- 0001765581-23-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-15 18:02:51
- Reporting Period:
- 2023-08-11
- Accepted Time:
- 2023-08-15 18:02:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1555132 | A. Catherine Sohn | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2023-08-11 | 3,075 | $0.00 | 16,109 | No | 4 | A | Direct | |
| Ordinary Shares | Disposition | 2023-08-14 | 1,241 | $138.16 | 14,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.
- Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Billionaire Hedge Funds
